Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Jerome H. Check & Diane L. Check. (2023) The role of progesterone and the progesterone receptor in cancer: progress in the last 5 years. Expert Review of Endocrinology & Metabolism 18:1, pages 5-18.
Read now
Read now
Articles from other publishers (10)
E. A. Grekov, I. A. Tyuzikov & A. V. Smirnov. (2023) Progesterone and prostate: a history of scientific study and the modern view of the problem. Andrology and Genital Surgery 24:1, pages 36-47.
Crossref
Crossref
Huijie Pu, Xiaosha Wen, DiXian Luo & Zifen Guo. (2023) Regulation of progesterone receptor expression in endometriosis, endometrial cancer, and breast cancer by estrogen, polymorphisms, transcription factors, epigenetic alterations, and ubiquitin-proteasome system. The Journal of Steroid Biochemistry and Molecular Biology 227, pages 106199.
Crossref
Crossref
Tatiana Meier, Max Timm, Matteo Montani & Ludwig Wilkens. (2021) Gene networks and transcriptional regulators associated with liver cancer development and progression. BMC Medical Genomics 14:1.
Crossref
Crossref
Jerome H. Check & Diane L. Check. (2021) A Hypothetical Model Suggesting Some Possible Ways That the Progesterone Receptor May Be Involved in Cancer Proliferation. International Journal of Molecular Sciences 22:22, pages 12351.
Crossref
Crossref
Yasunari Matsuzaka & Yoshihiro Uesawa. (2020) DeepSnap-Deep Learning Approach Predicts Progesterone Receptor Antagonist Activity With High Performance. Frontiers in Bioengineering and Biotechnology 7.
Crossref
Crossref
Xuan Che, Jianzhang Wang, Jiayi He, Qin Yu, Wenting Sun, Shuyi Chen, Gen Zou, Tiantian Li, Xinyue Guo & Xinmei Zhang. (2019) A new trick for an old dog: The application of mifepristone in the treatment of adenomyosis. Journal of Cellular and Molecular Medicine 24:2, pages 1724-1737.
Crossref
Crossref
Lindong Zhang, Quanling Feng, Zhiting Wang, Pingping Liu & Shihong Cui. (2019) Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism. Bioscience Reports 39:7.
Crossref
Crossref
Fei Gao, Chenyu Peng, Jindian Li, Rongqiang Zhuang, Zhide Guo, Duo Xu, Xinhui Su & Xianzhong Zhang. (2019) Radioiodinated progesterone derivative for progesterone receptor targeting with enhanced nucleus uptake via phenylboronic acid conjugation. Journal of Labelled Compounds and Radiopharmaceuticals 62:7, pages 301-309.
Crossref
Crossref
Martina Fragni, Chiara Fiorentini, Elisa Rossini, Simona Fisogni, Sara Vezzoli, Sara A. Bonini, Cristina Dalmiglio, Salvatore Grisanti, Guido A. M. Tiberio, Melanie Claps, Deborah Cosentini, Valentina Salvi, Daniela Bosisio, Massimo Terzolo, Cristina Missale, Fabio Facchetti, Maurizio Memo, Alfredo Berruti & Sandra Sigala. (2018) In vitro antitumor activity of progesterone in human adrenocortical carcinoma. Endocrine 63:3, pages 592-601.
Crossref
Crossref
Parth Malik & Tapan K. Mukherjee. (2018) Recent advances in gold and silver nanoparticle based therapies for lung and breast cancers. International Journal of Pharmaceutics 553:1-2, pages 483-509.
Crossref
Crossref